lightlake therapeutics inc (LLTP:OTCQB)
David Sinclair Ph.D.
Chief Science Officer, Lightlake Therapeutics Inc
|Age||Total Calculated Compensation||This person is connected to 78 board members in 5 different organizations across 6 different industries.|
See Board Relationships
Dr. David Sinclair, Ph.D. serves as the Chief Science Officer of Lightlake Therapeutics Inc. Dr. Sinclair is a Co-Founder of Genocea Biosciences, Inc. He served as a Venture Partner at Lux Capital Management since December 19, 2007. He Co-Founded Sirtris Pharmaceuticals, Inc. in 2004. In 1997, he identified the cause of aging in yeast, a first for any species, and in 2003 reported the discovery of a conserved master regulatory gene controlling this process. He serves ...
86 Gloucester PlacePhone: 44 20 3617 8739
London, Greater London W1U 6HP
Fax: 44 20 7034 1943
Board Members Memberships*
Director and Member of Strategic Advisory Board
Co-Founder, Director and Member of the Scientific Advisory Board
Member of The Board of Directors
Massachusetts Institute of Technology
University Of New South Wales
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA | Mack-sumner CommunicationsPosted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26